Drug profile · INN
sevelamer hydrochloride
TASERMITY
sevelamer hydrochloride (TASERMITY) is a phosphate sequestering agent. Route of administration: oral. Current US regulatory status: approved.
Drug details — sevelamer hydrochloride
- US status
- approved
- Class
- Various (V03)
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
sevelamer hydrochloride (TASERMITY) is a phosphate sequestering agent. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Phosphate sequestering agent
Primary target: Phosphate
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | unknown | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sevelamer hydrochloride?
sevelamer hydrochloride (TASERMITY) is a phosphate sequestering agent. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sevelamer hydrochloride?
TASERMITY is a marketed brand name for sevelamer hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sevelamer hydrochloride?
sevelamer hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.